Results 101 to 110 of about 44,417 (118)

Baricitinib in Juvenile Idiopathic Arthritis: An International, Phase 3, Randomised, Double-Blind, Placebo-Controlled, Withdrawal, Efficacy, and Safety Trial

Lancet, The, 2023
Ralf Trauzeddel, Inmaculada Calvo Penadés, Zhixuan Zhou   +2 more
exaly  

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

New England Journal of Medicine, 2012
Alberto Martini, Pavla Doležalová, Nicolino Ruperto   +2 more
exaly  

Adalimumab Plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis

New England Journal of Medicine, 2017
Ashley P Jones, Sandrine Compeyrot-Lacassagne, Dyfrig A. Hughes   +2 more
exaly  

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

New England Journal of Medicine, 2012
Gerd Horneff, Alberto Martini, Nicolino Ruperto   +2 more
exaly  

Juvenile Idiopathic Arthritis

Lancet, The, 2011
Alberto Martini, Berent Prakken, Salvatore Albani   +2 more
exaly  

Abatacept in Children With Juvenile Idiopathic Arthritis: A Randomised, Double-Blind, Placebo-Controlled Withdrawal Trial

Lancet, The, 2008
Alberto Martini, Nicolino Ruperto, Clovis A Silva   +2 more
exaly  

Etanercept in Children With Polyarticular Juvenile Rheumatoid Arthritis

New England Journal of Medicine, 2000
Norman T Ilowite, Andreas Reiff, Earl D Silverman   +2 more
exaly  

Juvenile Chronic Arthritis

Lancet, The, 1998
P Woo, L R Wedderburn
exaly  

Leflunomide or Methotrexate for Juvenile Rheumatoid Arthritis

New England Journal of Medicine, 2005
Gerd Horneff, Earl D Silverman
exaly  

Efficacy and Safety of Tocilizumab in Patients With Systemic-Onset Juvenile Idiopathic Arthritis: A Randomised, Double-Blind, Placebo-Controlled, Withdrawal Phase III Trial

Lancet, The, 2008
Takako Miyamae, Tadamitsu Kishimoto, Masaaki Mori   +2 more
exaly